Sponsor Dossier
Specialites Septodont
Sponsor Dossier for Specialites Septodont. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ATO
- Brand: DELTAZINE
- Brand: LIGNOSPAN SPECIAL
- Brand: Racestyptine
- Brand: SCANDONEST
- Brand: SEPTANEST
- Brand: XOGEL
- Brand: XYLONOR
- Device (sponsor): BioRoot Flow - Hygroscopic dental cement
- Device (sponsor): Biodentine XP - Hygroscopic dental cement
- Device (sponsor): Dental amalgam alloy dispenser
- Device (sponsor): Hemogelatin - Gelatin haemostatic agent
- Device (sponsor): Mixer, dental, amalgam
- Device (sponsor): R.T.R.+ 40/60 - Bone matrix implant, synthetic
- Device (sponsor): R.T.R.+ 80/20 - Bone matrix implant, synthetic
- Device (sponsor): Syringe, dental, anaesthesia
- Device (sponsor): Manual non-rotary dental instrument handle
- Device (sponsor): Manual non-rotary dental instrument handle
- Device (sponsor): Dentapen - Syringe, dental, anaesthesia
- Device (sponsor): Syringe, <specify>
- Device (sponsor): Impression material, dental, alginate
- Device (sponsor): Mixer, dental, amalgam
- Device (sponsor): Dental anaesthesia injection kit, non-medicated
- Device (sponsor): Syringe, dental, <specify>
- Device (sponsor): Biodentine - Hygroscopic dental cement
- Device (sponsor): Needle, dental
- Device (sponsor): Gingival retraction solution
- Device (sponsor): Dressing, dental, periodontal
- Device (sponsor): Impression material, dental, alginate
About
Specialites Septodont is an Australian Private Company with ABN 27002881861, incorporated in Queensland and currently active.
Portfolio
Specialites Septodont's ARTG portfolio comprises 9 brands, of which 8 are indexable and 8 have Product Information on file. One brand has a PBAC outcome on record. Notable brands include ATO, DELTAZINE, LIGNOSPAN SPECIAL, Racestyptine, SCANDONEST, SEPTANEST, XOGEL, XYLONOR, and Ziagel.
Therapeutic focus —
Pain & Anaesthesia: 6 brands — Pain Management: 2 brands — Other: 1 brand
Regulatory activity
Specialites Septodont's most recent PBAC outcome was recorded on 1 November 2021.